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ABSTRACT:  Health  state  utility data  generated  using  the  EQ-5D instrument  are 
typically right bounded at one with a substantial gap to the next set of observations, 
left bounded by some negative value, and are multi modal. These features present 
challenges to the estimation of the effect of clinical and socioeconomic characteristics 
on health  utilities.   We  present  an adjusted  censored  model  and then  use this  in 
a flexible, mixture modelling framework to address these issues.  We demonstrate 
superior performance of this model compared to linear regression and Tobit censored 
regression using a dataset from repeated observations of patients with rheumatoid 
arthritis.   We  find that  three  latent  classes  are  appropriate  in estimating  EQ-5D 
from function,  pain and sociodemographic factors.  Analysis of utility data should 
apply methods that recognise the distributional features of the data. 
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1    Introduction 
 
 
The Quality Adjusted Life Year (QALY) has become one of the most widely used 
outcome measures in economic evaluations.  The QALY  is useful to healthcare deci- 
sion makers seeking to apply a consistent approach across a broad range of disease 
areas, treatments and patients and is required by several international bodies, such 
as the National Institute for Health and Clinical Excellence (NICE) in England and 
Wales (NICE (2008)). Typically,  QALYs are generated from patient completion of 
a survey instrument that provides a generic description of health in terms of symp- 
toms and impact on functioning, to which standardised, preference based scoring 
systems can then be applied.  Instruments such as the EQ-5D, SF6D and Health 
Utilities Index (HUI) are in widespread use. Other approaches to generating QALYs 
include the use of disease specific instruments which have similar preference based 
scoring systems or direct valuation of health states by patients themselves.  It is well 
documented that the use of different approaches or instruments results in different 
estimates of health state utilities, and therefore, ultimately, different estimates of 
cost  effectiveness  and decisions.   As  a consequence,  some decision  makers  express 
a clear preference for the use of a particular approach. In England and Wales for 
example, NICE recommends the EQ-5D (NICE (2008)). 
Clinical studies, and in particular randomised controlled trials, used to estimate 
the treatment effect of a health technology often do not include any preference based 
outcome measures.  Furthermore, even where such outcomes are included, they may 
not be relevant to the setting for the economic evaluation.  There may therefore be 
a gap between the data available from the clinical studies and the requirements of 
the economic evaluation. 
In some situations it may be possible to bridge this gap by estimating the rela- 
tionship between a clinical measure(s) and a preference based measure where both 
have been included in an external dataset.  This then provides a statistical link 
between the treatment effect observed in the clinical studies using clinical outcome 
3  
 
measures and a preference based measure that can be used to estimate QALYs in 
the  economic  evaluation.   The  fitting  of a statistical  model  for this  purpose  has 
been referred to in previous literature as "mapping" or "crosswalking",  borrowing 
terminology from psychometrics.  There are other situations where one may wish to 
fit a statistical  model  to health utility data,  for example to explore the impact of 
socioeconomic factors or treatments directly. 
A recent review of 30 studies (Brazier et al. (2009)) indicates that the statistical 
models used tend to be relatively simplistic.  Simple linear models dominate, with 
limited  use  of Tobit  or similar  models  for dealing  with  censored  data.   However, 
health  state  utility data  tend  to  exhibit  features  which may call for more flexible 
statistical models.  In addition to upper bounding at full health (l), utility data are 
also  left  bounded at  the  worst  imaginable  health  state,  have gaps between  values 
and tend to have distinct bi or tri-modal distributions.  Furthermore, both clinical 
trials and observational studies typically include multiple observations from each 
individual.  Statistical models used to estimate health state utilities ought to reflect 
these data characteristics in order to avoid biased estimates.  This is now well recog- 
nised in relation to health related costs where the use of generalized linear multilevel 
(sometimes called random effects or hierarchical) models have been discussed to deal 
with left boundedness, skewness and the clustered nature of the data (Hernandez 
Alava and Wailoo (20l0), Thompson et al. (2006)). 
In this  paper we develop  an adjusted  censored  regression  to  address  the  right 
censoring and the gap between full health and intermediate health states that is a 
feature of EQ-5D. We then develop flexible, random effects mixture (or latent class) 
models to account for the other key features of the distribution of EQ-5D values. 
Section 2 provides a detailed account of the statistical  issues to be addressed and 
outlines how these have been considered in the literature to date.  Then in section 
3 we describe the data and methods.  This first covers a description of an example 
dataset from a trial of patients with rheumatoid arthritis (RA)  and then describes 
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the statistical models to be applied. Results are provided in section 4. Section 5 
provides a discussion of the results and the implications of the models estimated 
here. 
 
 
 
2    Background 
 
 
2.1     The typical  distribution of EQ-5D 
 
 
The EQ-5D questionnaire asks respondents to describe their health in five domains 
(mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of 
which can be at one of three severity levels (no problems/some or moderate prob- 
lems/extreme problems).  243 combinations can be described in this way.  A score 
can be assigned  to  each of these  states  based  on analysis  of preference  data  ob- 
tained from approximately 3,000 members of the general public in the UK Dolan et 
al. (l995). 
Figure l displays the distribution of health state utilities derived using UK pref- 
erence  weights  for the  widely used EQ-5D instrument  from ll studies  in different 
clinical areas.  Several features should be noted.  First, there is often a mass of ob- 
servations at l, full health, which is the maximum value feasible for health utility. 
There  is  then  a relatively  large  gap before  the  next  observations  which begin  at 
0.883. 0.883 is the highest utility score that can be generated using the UK regres- 
sion model for scoring EQ-5D reported by Dolan et al. (l995) and applies to the 
health state ll2ll, that is, where the patient indicates that the only reduction from 
full health is by having "some problems" with their usual activities.  The score of 
l, that is, full health, is not capable of being generated by the Dolan model.  Thus, 
there is no connection between the value for full health and the values for all other 
health states accounting for this first large gap in observed EQ-5D scores. 
Second, for each of the examples, the distribution of values are bi or tri-modal 
with  each of the  separate  components  of the  distribution  centred  around 0.7 and 
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0.2 approximately.  Their precise location, the degree of kurtosis and skew in each 
of these components varies according to the specific setting and, in particular, the 
severity  of the  condition.   The  lower  section  of the  distribution  is  a consequence 
of the  "N3"  term  in the  scoring  model  which assigns  a large  utility decrement  to 
any health state that includes extreme problems in any dimension.  Furthermore, 
these  characteristics  are  not  limited  to  health  utilities  generated  via the  UK  EQ- 
5D scoring  model.    The  US  scoring  of EQ-5D for example  also  demonstrates  a 
large gap between full health and the next set of values at 0.86, Shaw et al. (2005) 
and apparently separate components of the distribution below this level.  Huang et 
al. (2008) presents a histogram of US EQ-5D valuations from patients with HIV that 
demonstrates this gap as well as the multi modal characteristic of the distribution. 
The process of building a statistical model which uses EQ-5D as the dependent 
variable should recognise these features in order to avoid biased estimates. 
 
 
2.2     Existing literature 
 
 
 
 
Brazier et  al. (2009) identified 30 studies  which examine the  relationship between 
health outcome measures that are not preference based and generic preference-based 
measures.  Of these, half used the EQ-5D as the dependent variable, with variants of 
the Health Utilities Index (HUI) in 8 studies and SF-6D in 5 studies.  AQoL, QWB 
and l5D were included in the remainder with some studies including more than one 
measure. 
The authors of the review reported that the vast majority of the included stud- 
ies fitted straightforward linear models.  There was very limited use of censored 
regression models or any attempt to deal with the non normal characteristics of the 
distribution of values.  Typically  scant attention is paid to model diagnostics.  The 
R2  statistic was seen to dominate model selection in these studies, notwithstanding 
the fact that R2  cannot be used to compare models with different dependent vari- 
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Figure l:  Distribution of EQ-5D from ll studies in different clinical areas 
 
Asthma (n=2,935) 
 
 
30% 
 
25% 
 
20% 
 
15% 
 
10% 
 
5% 
 
0% 
 
EQ•5D s core 
Chest pain (n=679) 
 
 
30% 
 
25% 
 
20% 
 
15% 
 
10% 
 
5% 
 
0% 
 
EQ•5D s core 
Cronic obstructive pulmonary  disease 
(n=185) 
 
16% 
14% 
12% 
10% 
8% 
6% 
4% 
2% 
0% 
 
EQ•5D s core 
Clodronate  (n=320) 
 
18% 
16% 
14% 
12% 
10% 
8% 
6% 
4% 
2% 
0% 
 
EQ•5D s core 
Hormone replacement  therapy (n=755) 
 
35% 
30% 
25% 
20% 
15% 
10% 
 
0% 
 
EQ•5D s core 
Irritable bowel syndrome (n=374) 
 
35% 
30% 
25% 
20% 
15% 
10% 
 
0% 
 
EQ•5D s core 
Lower back pain (n=500) 
 
25% 
 
20% 
 
15% 
 
10% 
 
5% 
 
0% 
 
EQ•5D s core 
Leg Ulcers (n=233) 
 
14% 
12% 
10% 
8% 
6% 
4% 
2% 
0% 
 
EQ•5D s core 
Leg reconstruction (n=92) 
 
25% 
 
20% 
 
15% 
 
10% 
 
5% 
 
0% 
 
EQ•5D s core 
Osteoporosis  (n=221) 
 
25% 
 
20% 
 
15% 
 
10% 
 
5% 
 
0% 
 
EQ•5D s core 
Varicose veins (n=887) 
 
45% 
40% 
35% 
30% 
25% 
20% 
15% 
10% 
5% 
0% 
 
EQ•5D s core 
 
7  
 
ables and a raft of other criticisms of this approach that are well documented in the 
econometrics literature, see for example Charemza and Deadman (l992). 
Several other authors have considered the use of Tobit and other censored re- 
gression models for dealing with the bounded nature of health utility data.  These 
studies were not included in the Brazier et al. (2009) review because they do not at- 
tempt to model the relationship between health preference data and other outcome 
measures but are instead interested in the impact of the determinants of health or 
socioeconomic factors.  Austin et al. (2000) conducted a simulation study to com- 
pare linear regression models to Tobit censored models and found Tobit performed 
better in the presence of censoring.  Austin (2002) also compared linear regression 
with the Tobit model  and variants of the Tobit:  the symmetrically trimmed least 
squares  and censored  least  absolute  deviations  (CLAD)  models  using  data  on the 
HUI from a large  Canadian population  health  survey.   Huang et  al. (2008) found 
that the CLAD model performed poorly in a study using the EQ-5D (US scores) as 
the  dependent  variable  based on data from HIV infected patients.  They reported 
consistently better performance from latent class models and two-part models where 
a log transformation is used in the second part.  The focus of this study was solely on 
methods to address the mass of observations at one and for this reason they include 
only two latent classes.  However, it is unclear that a two class model is capable of 
overcoming this challenge unless either the underlying distribution for the classes is 
itself suitable for censored data or if one class has a zero variance in which case the 
model  is  equivalent  to  the  two  part  model.  Similarly,  Li and Fu (2009) applied  a 
two part model to US EQ-5D data.  Specifically they explored how the second part 
of the model, for those individuals that do not score one, may be approached in a 
number of ways. 
 
 
Pullenayegum et al. (20l0) compared the performance of Tobit, CLAD, linear re- 
gression, two-part and latent class models when modelling data that are constrained 
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by one.  As  with  Huang et  al. (2008), only two  latent  classes  were  included,  both 
with normal distributions.  They reported that both Tobit and CLAD models yield 
biased estimates when the variable of interest is not able to exceed one rather than 
simply being censored by the measurement instrument at one.  Linear regression, 
latent class model and the two part estimators were reported as unbiased. 
No studies have developed methods to deal with the numerous challenges that 
are presented by the distribution of EQ-5D data.  Of particular note is that the use 
of latent  class  models  has been limited to addressing the issue of upper censoring 
but, as previously mentioned, it is not clear that the general framework provided by 
this approach has been fully  exploited to date.  A general problem with modelling 
of EQ-5D utility values to date is that the fit of the models is poor at the extremes 
of the distribution.  Specifically, models tend to underpredict at the upper extreme 
of the EQ-5D scale and overpredict over much of the remainder of the scale but 
particularly at the lower end, Brazier et al. (2009), Rowen et al. (2009). Therefore, 
as Crott and Briggs (20l0) note, there is currently no agreement of the best method 
to use. Studies have not applied the same criteria for judging the appopriateness of 
models and there are differences in the characteristics of the datasets used in these 
studies that may influence the findings. 
 
 
 
3    Data and  Methods 
 
 
3.1     The Rheumatoid Arthritis dataset 
 
 
Rheumatoid  Arthritis  (RA)  is  the  most  common form of inflammatory  arthritis 
with prevalence estimated at 0.8% of the population,  Symmons et al. (2002), and 
incidence  between  l.5  per  l0,000  for males  and 3.6 per  l0,000  for females  in the 
UK,  Cooper (2000).  In recent  years,  treatment  of this  condition  has been vastly 
altered  by the  development  of so-called  biologic drugs.   Whilst  proven  to  be clin- 
ically efficacious,  their relatively high cost make them obvious candidates  for cost 
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effectiveness  analyses.   Thus,  there  has been an explosion  in the  number  of such 
studies undertaken in this field. 
Almost all these economic evaluations are based on models which define health 
states or profiles in terms of the Health Assessment Questionnaire Disability Index 
(HAQ) (NICE (2009), Wailoo et al. (2008), Chen et al (2006), Kobelt et al. (2002)). 
This is a validated clinical outcome measure that focuses on the functional capacity 
of a patient and there is a de facto mandatory requirement for its inclusion in RA 
clinical trials, Aletaha et al. (2008).  The HAQ covers 8 categories of functioning 
(dressing,  rising,  eating,  walking, hygiene,  reach,  grip, and usual activities) and is 
scored from 0 (no disability) to 3 (completely disabled) in steps of 0.l25, although 
the scale is generally treated as fully  continuous.  Since preference based measures 
of outcome that would allow direct modelling of QALYs were not included in many 
of the clinical trials in this area, nor in the studies that inform methods of extrapo- 
lation beyond the trials, it becomes necessary to statistically model the relationship 
between HAQ and a preference based measure of health related quality of life in 
order to estimate QALYs. 
A number of such models have been reported, many of which are used in economic 
evaluations.  These cover a range of preference based instruments including EQ-5D 
(Bansback et al. (2009), Hawthorne et al. (2000), Hurst et al. (l997), Lindgren et 
al (2009), Marra et al. (2007), Wailoo et al. (2008)), SF6D (Bansback et al. (2009), 
Marra et al. (2007),Wailoo et al. (2008)), HUI2 and HUI3 (Bansback et al. (2005), 
Marra et  al. (2007)).  Almost  all are  simple  linear  regression  models.   In general 
these studies only consider HAQ as a covariate, although some studies include age 
(Marra et al. (2007), Wailoo et al. (2008)), gender (Bansback et al. (2005), Wailoo 
et al. (2008), Lindgren et al (2009)), or other clinical measures such as pain (Hurst 
et al. (l997)), disease activity (Hurst et al. (l997), Lindgren et al (2009)), or disease 
duration (Wailoo et al. (2008)). 
Most consider only a linear relationship between HAQ and health utility. Malottki 
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Figure   2:  Histogram of EQ-5D  from  patients with  rheumatoid arthritis used  m 
current study 
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et  al.  (2009) include  a quadratic term  for HAQ making  the  relationship to EQ-5D 
non-linear.  Wailoo  et  al.  (2008)  use a  non  linear  regression  with  logistic  function 
to constrain the  predicted values of the feasible  range  of the  EQ-5D/SF6D instru- 
ments.  Bansback et al. (2009) models the individual domains of HAQ as explanatory 
variables  rather than the  HAQ summary measure  and is therefore  a quite  different 
approach to the other publications. 
Here we use a new, rich dataset to estimate the relationship between EQ-5D and 
HAQ as well as other  relevant  explanatory variables.  The  data  come from the Com- 
bination Anti-Rheumatic Drugs  in Early  Rheumatoid Arthritis (CARDERA) Trial 
(Choy  et  al.  (2008))  comprising 467 patients randomised to  receive four  different 
drug  treatment strategies. Patient outcomes were assessed at  baseline, 6, 12, 18 and 
24 months. 
 
Whilst   this  was a patient population with  recently  (within  2 years)  diagnosed 
RA,  the spread  of patients across the entire  feasible ranges of both  HAQ and EQ-5D 
make  this  a dataset well suited  for the  current problem.    As is typical  with  most 
studies, particularly clinical trials  which tend  to recruit  relatively  healthier patients 
than in  clinical  practice,   there   is  a  relative paucity   of  observations at the most 
ll  
it 
ki i 
i ki it 
i   
i 
 
extreme level of functional limitation, that is a HAQ score of 3. 
 
The data shown in Figure 2 clearly demonstrate the typical pattern in EQ-5D 
data.  There is a mass point at l (full  health) and a clear gap until the next set of 
values.  There  are  at  least  two  other  groupings  - one between  0.5 and 0.85 which 
has a left skew and another centred around zero.  The data span the entire range of 
feasible EQ-5D values. 
 
 
3.2  Models 
 
 
We estimated models within four broad classes. 
Model 1:  Random effects linear regression.  We use a standard linear 
regression with random coefficients to reflect the fact that each patient provides 
values at several timepoints during the study.  The estimated model for yit  (EQ-5D 
for individual i -level 2 or between level units, and time period t - level l or within 
level units) can be written as: 
 
 
 
 
 
yit - x
   f3 + Eit 
 
f3 -   ak  + uki 
 
 
 
where f3    is a (k x 1) vector of random coefficients f3    , x      is a row vector of level 
 
l covariates,    is a row vector of level 2 covariates,  Eit   is l l D N (0, 02 ), uki   is an 
 
element of the (k x 1) vector uk  which is N (0, D) and Eit  is independent of all the 
uki.  In principle, this general specification allows all the coefficients in the vector f3i 
to be random. The majority of applications where a random effects linear regression 
model is used allow only the intercept to vary randomly. 
 
Model  2:  Random effects  Tobit  model.  The linear regression assumption 
is  problematic  because it implies  that  values  outside  the  EQ-5D lower  and upper 
boundaries  can be generated  by the  model.   The  Tobit  model  takes  into  account 
l2  
it 
it 
it 
y* 
 
not only that our dependent variable is censored at one but also that there may be 
a substantial concentration of observations at the censored point (full  health)l .  A 
latent  variable,  y* , is  defined with  a conditional  normal distribution.   This  latent 
variable is artificially censored at one in our case, turning the usual regression model 
into a model with a discrete element at the censored point and a continuous model 
elsewhere.  The top panel of Figure 3 shows the differences between the distributions 
implied by the linear regression and the Tobit models and how the Tobit model is 
able to generate a concentration of observations at the tail of the distribution.  This 
is  essentially  an ad hoc modification  of the  previous  linear  regression  model  l in 
order  to  account  for these  features.   In many applications,  the  latent  variable  y* 
is given some meaning.  For example, when modelling the number of hours worked 
using a Tobit model, the latent variable is often thought of as the "desired hours of 
work" which may be negative.  However, the derivation of the original Tobit model 
(Tobin, l958) does not require any interpretation of the latent variable.  The random 
effects Tobit model can be written as: 
 
 
yit - min {y* , 1} 
 
it - xitf3i  + Eit 
 
f3ki - i ak  + uki 
 
 
 
Model  3:  Random effects  Adjusted  Censored  Model  (ACM). Another 
key feature of EQ-5D data is that it is not feasible to generate values between 0.833 
and l.  The EQ-5D instrument is relatively crude and may be insufficiently sensitive 
to detect minor departures from full health.  Departures from full health are scored 
as  equivalent  to  full  health  unless  they  are  sufficient  to  reduce  patient  quality  of 
life on at least one of the five dimensions in the EQ-5D instrument.  Therefore, the 
l It does not deal with the lower limiting  value although it can easily be modified to do so. In 
our dataset, we have very few observations at the bottom end of the distribution so we make  no 
attempt to deal with this issue. 
l3  
it 
   y* 
 
standard Tobit  model  is  not  sufficient  since  it deals  with the  upper censoring but 
not with the gap between one and the next feasible value.  We modify the Tobit 
model so that the concentration of observations at l is accompanied by a gap to the 
next set of observations at 0.883. The peak at l is therefore comprised both of the 
gap to the left and the censoring to the right.  the model can be written as follows: 
 
 
 
 
 
 
yit - 
r 
)    1 if y* 
 
> 00    
it otherwise 
 
y*
 
it - xitf3i  + Eit 
 
f3ki - i ak  + uki 
 
 
 
An example  of a distribution  generated  by this  type  of model  can be seen in the 
lower panel of Figure 3. 
Model 4: Random effects Adjusted Censored Mixture Model (ACMM). 
The last feature of the EQ-5D data that none of the previous models deal with is the 
multi-modality of the distribution and possible departures from normality across the 
rest of the distribution.  This feature can be the result of unobserved heterogeneity 
in the form of latent classes.  Intuitively, the population may be made up of several 
groups,  or "latent  classes",  with  potentially  different  relationships  to  the  depen- 
dent variable.  These models can be estimated by using mixtures (McLachlan and 
Peel (2000)).  Mixtures are very flexible and can well accommodate the statistical 
challenges posed by typical EQ-5D distributions. 
Conditional on an observation belonging to class Cit, the model becomes: 
l4  
) 1 if 
* 
y* 
it 
it \  it �p 
it 
  it   
 
 
 
 
 
yit\Cit - 
r 
y* it\Cit 
 
> 00 
it\Cit otherwise 
 
yit\Cit - xitf3ic  + Eitc 
 
f3kic - i akc + uki 
 
 
We assume a multinomial logit model for the probability of latent class member- 
ship: 
 
 
 
 
 
 
 
where wt 
P (C   - c w  ) - 
exp (wt  8c ) 
s=l exp (wt  8s) 
 
is a vector of variables that affect the probability of class membership, 8c 
 
is the vector of corresponding coefficients and P is the number of classes.  Note that 
it is  possible  when estimating  this  model  (and also  a general  latent  class  model) 
to find that the mean of one of the classes is one, irrespective of the values of the 
covariates,  and its  variance  tends  to  zero.   In this  case,  if the  optimal  number  of 
classes is two, the resultant model is analogous to the two part or hurdle model. 
Whilst we apply adjusted censored normal distributions for each of the latent 
classes, as the mean of the distribution moves away from the censoring point and/or 
the variance decreases, so the distribution tends to that of the normal. 
Some judgment must be used in determining the appropriate number of latent 
classes since the usual likelihood ratio test cannot be used to test nested latent class 
models.  Some of the parameters (the variances of the latent classes) are on the 
boundary of the parameter space which distorts the distribution of the statistic and 
thus the usual test cannot be applied.  The Bayesian Information Criteria (BIC) is a 
recommended, good indicator of the appropriate number of classes as well as plots of 
the likelihood values for models with different classes to identify a flattening of the 
likelihood values.  This indicates where the addition of further latent classes does not 
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improve the likelihood substantially (Nylund et al. (2007)). It is worth noting that 
as the number of classes is increased, the model can be viewed as semiparametric, 
a midpoint between a fully parametric model with a single latent class (or mixture 
component) and a nonparametric model in the case where the number of components 
equals the sample size.  If the aim is to achieve the best fit possible, increasing the 
number of classes based only on BIC for example might be a good idea although in 
this case the classes might loose their meaning.  If the aim is however to fit a model 
where the classes have a substantive meaning so that it can be used for out of sample 
predictions then a compromise between the BIC and consideration of the size and 
differences between the latent classes is needed to prevent the inclusion of latent 
classes with a very small size including perhaps only a small number of outliers. 
Figure 3 compares an example distribution generated by this model to models l to 
3. 
 
All  these models can be estimated using maximum likelihood.  Robust standard 
errors  using  a sandwich  estimator  are  used  for all the  models  to  protect  against 
non-normality.  All  analyses were undertaken using the Mplus programme, Muth€n 
and Muth€n  (2008), except  for those  based  on adjusted  censored  models  which 
were programmed in GAUSS, GAUSS (2008). The problems of estimating mixture 
models are well documented in the literature due to multiple optima of the likelihood 
function.  Using only one run of the usual local optimisation algorithms typically 
leads to finding only a local maximum. To overcome this problem, Mplus uses a large 
set of random starting values for a few iterations of an Expectation Maximisation 
algorithm before selecting a few promising values to optimise fully.  The parameter 
values that achieve the highest likelihood are then selected as the global maximum. 
For the adjusted censored models we used a global optimisation algorithm, simulated 
annealing (Corana (l987);  Goffe et al. (l994)) to obtain a starting value near the 
final solution.  A stopping rule was applied to ensure that the function was in the 
vicinity of a global maximum. We then switched to a local maximisation algorithm 
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for the final optimisation stages (see Hernandez Alava (2002) for the first application 
of simulated annealing to the optimisation of mixture models that we are aware of ). 
Scripts of the codes and details of results for all models that were run are available 
from the authors on request. 
There  is  a tendency  for models  to  be compared in terms  of their  goodness  of 
fit.  Typically  R2  or adjusted R2  are used but there are various other measures of 
"error" that are widely reported and are used to choose between models, for exam- 
ple, the Mean Error (ME),  Mean Absolute Error (MAE)  and Root Mean Squared 
Error (RMSE). Such summary measures provide an indication of the magnitude of 
the  difference  between  the  observed  and predicted  values  but  are  of limited  value 
for model comparisons (see Charemza and Deadman (l992) for a discussion of the 
dangers of using R2 /R- 2 ). Particularly in the situation where we wish to use such es- 
 
timates in decision models that cover a large spectrum of disease, that is, predicting 
across a wide EQ-5D range, it is essential that no systematic bias is introduced and 
that  predictions  lie  in the  feasible  range.  Summary measures  of model  prediction 
do not provide a basis for choosing between models in this situation. 
In what follows, we compare models using a range of plots and criteria.  Model fit 
is described using penalised likelihood criteria (Akaike Information Criteria (AIC) 
and BIC). 
 
 
 
4    Results 
 
 
We initially compared linear and Tobit models using only HAQ and patient demo- 
graphic variables age and sex (age is centred at its sample mean and measured in 
ten year units).  We found that the inclusion of HAQ2 , thereby allowing a non linear 
relationship with EQ-5D was warranted.  Similarly, the inclusion of age2  improved 
the models.  In all models we found a positive association between EQ-5D and age, 
conditional on HAQ. This is consistent with previous literature both in RA (Marra 
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Figure 3: Illustrative histograms of possible model  distributions 
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et  al.  (2007),  Wailoo et  al. (2008)) and  other conditions (see for example Goldsmith 
et  al.  (2010)).  We  included the  follow  up  times  as  separate  covariates to  test  for 
any  effect  of disease  duration but  these  were grossly  insignificant and  not  retained 
in  any  of the  models.  The  preferred models are  a random effects  linear regression 
and  a Tobit model  with  two  independent random effects  for  the  intercept and  the 
coefficient  of HAQ.  In identifying the  preferred specification of the  models, we con- 
sidered a range of options. These included a standard Tobit with  no random  effects, 
one,   two  and  three random effects  (for  the  intercept and  the  coefficients of HAQ 
and  HAQ2 ), both considered as either independent or  correlated, and  the  inclusion 
of an  inflation factor for  the  censoring point.  The preferred Tobit specification in- 
eludes  two independent random effects  and  achieved the  lowest  information criteria 
compared to the  alternative Tobit specifications. The linear  regression has  a lower 
AIC  (-624.0  vs 32.1)  and  BIC  (-579.2  vs 99.4)  than the  Tobit model. This is due  to 
the  fact  that the  observations include a substantial peak  at  EQ-5D scores  of about 
0.5,  thereby pulling down  the  estimates for  the  linear regression and   causing the 
observations around one to have  less influence. Importantly, within the  sample the 
linear regression does  not  predict values  exceeding unit y. 
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The inclusion of pain measured on a Visual Analogue Scale (VAS) vastly im- 
proved the models, results for which are shown in Table l.  Pain is one of the most 
heavily weighted items in the EQ-5D valuation regression but does not feature in the 
HAQ summary score.  Previous studies focus on function but the trial data provided 
an opportunity to include this missing dimension of quality of life in the analysis. 
For the linear regression the AIC reduced to -l058.2 and the BIC reduced to -l007.7. 
With the inclusion of pain, the preferred specification of the Tobit model required 
only one random effect,  a random intercept.   The  AIC reduced  to  -345.6 and the 
BIC reduced to -295.l.  Thus, the apparent heterogeneity in the coefficient of HAQ 
may be explained by the omission of the pain covariate.  The linear regression still 
outperforms  the  Tobit  model  in terms  of model  fit.  In addition  to  AIC and BIC, 
the ME, MAE and RMSE are approximately equivalent on the utility scale.  How- 
ever, there are other aspects of the performance of the linear regression that warrant 
consideration.  Most importantly, the predicted values can exceed one.  Within the 
current sample this is not the case, as with the models excluding pain, but when 
predicting out of sample, unfeasible predictions will be generated.  Furthermore, the 
predicted values from the linear regression do not reflect the characteristics of the 
underlying data in other ways.  In particular,  the mass of observations at one but 
also the gaps and multi-modality of the distribution are not well  reflected by this 
model as demonstrated in Figure 4  by the histogram of the predicted values. 
The RE Tobit model addresses the issue of censoring and Figure 4 illustrates that 
there is a resultant peak in values close to one.  The RE adjusted censored model 
develops this further to address the gap between full health and all intermediate 
health  states.   Table  l shows that  model  fit, measured  by the  information  crite- 
ria, is improved substantially compared to the unadjusted RE Tobit model.  More 
importantly, the distribution of predicted values illustrate that the model captures 
the key feature of the data at the top of the distribution.  The difference is slight 
when considering  the  predicted  values  but  there  is  a more pronounced rise  in the 
l9  
 
density at higher values of HAQ. Note however that the distribution of expected 
values will not itself demonstrate the peak at one with the subsequent gap since this 
plot smooths out such peaks.  This is a feature of the underlying adjusted censored 
model, not the resultant expected values.  The predicted values are averages across 
individuals  so although  no individual  will  have a value  between  l and 0.883, the 
predicted values can lie in this range. 
We considered a variety of mixture models.  The models varied in terms of the 
underlying distributions that comprised the mixture.  We considered mixtures of 
normal, Tobit  and adjusted  censored  models.   It was considered  that  the  models 
that included three latent classes were preferred.  We chose three latent classes 
considering mainly the BIC balanced against consideration of the size of the latent 
classes.  There is a danger in the inclusion of an excessive number of latent classes 
where a class may include only a small number of outliers.  This phenomenon is 
clearly observed when we move from a model with three latent classes to a model 
with four.  The model for the four latent classes essentially splits one of the latent 
classes of the three class model, the class at the highest levels of HAQ. One of these 
two classes is quite substantial in size but the other class is not.  In fact we find that 
only l3 observations out of the 2003 in our sample are most likely to be in this class. 
In addition,  the  increase  in the  likelihood  value  is  not  as substantial  as when  the 
classes  are  increased  from two  to  three  also  signalling  that  this  latent  class  is  not 
substantial enough and might just contain a few outliers.  Initially the model with 
three latent classes contained a HAQ2  term in all the classes.  However, it was found 
that the estimated coefficients for HAQ and HAQ2  in latent class l were insignificant 
but very highly correlated and therefore only a linear term was needed in this class. 
Table 2 demonstrates that this further development produces a model that vastly 
outperforms the non mixture models.  The information criteria are both substantially 
lower than the other models.  The average errors are smaller on all measures and, 
although the scale of EQ-5D can mask these differences, we see an approximate 4% 
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improvement in MAE and l% in RMSE compared to the standard RE linear model. 
 
The model identifies three separate latent classes which demonstrate different 
relationships between EQ-5D, function and pain. Table 3 shows the summary char- 
acteristics of the observations when grouped by the latent class with the most prob- 
able membership.  The groups are clearly different in terms of functional disability 
and pain.  Class  l has a mean HAQ of 2.26 indicating  substantial  disability,  and 
a high pain score mean of 72.l.  This reflects the element of the data distribution 
at the bottom of the EQ-5D scale.  Class 2 has the least disability as measured by 
HAQ and the least amount of pain. The third class has moderate pain (mean 33.3) 
and functional disability (mean l.24 HAQ). Classes 2 and 3 are both required in 
order to reflect the concentration of observations at one and the peak in the skewed 
distribution below this.  It is the mixture of two latent classes with different means 
and variances that reproduces this skew. 
Table 2 shows that for latent class l, only a linear term on HAQ is needed and the 
coefficient for pain is both large and significant.  Latent class 2 has a non significant 
coefficient for pain.  Both HAQ and HAQ2  are significant and relatively large,  the 
latter negatively so.  This results in a U - shaped relationship between HAQ and the 
latent  variable,  where  the  latter is  predicted to  increase  once the  HAQ functional 
ability deteriorates beyond around 2. The reason for this is that the model is trying 
to incorporate the small number of outliers that occur at the highest HAQ value 
where we see very few observations.  For the third latent class, both HAQ and pain 
covariates are significant.  The quadratic HAQ coefficients result in a deterioration 
in the latent variable as function decreases, but at a decreasing rate within the 
feasible range.  The size of the coefficients and their implications cannot be judged 
directly since this is a highly nonlinear model.  Table 4 presents examples of the 
predicted values for selected combinations of covariates.  For a female of average age 
in the sample and both HAQ and pain of zero the predicted EQ-5D is 0.94. We see 
that the expected values for each class range from 0.34 for class l to 0.98 for class 
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2.  The predicted probabilities of latent class membership are very different.  This 
individual has a zero probability of being in class l and a high predicted probability 
(0.77) of being in class 2, the class with the highest expected EQ-5D value.  Thus the 
predicted EQ-5D value lies in between that of class 2 and class 3. As pain increases, 
the predicted EQ-5D value goes down, but the relationship is not linear (unlike the 
linear regression model which implies that a change in pain will always lead to the 
same change in the predicted EQ-5D regardles of the levels of pain). The expected 
values for each of the classes decrease and the probabilities change dramatically. 
When pain is very high (93) the probability of class 3 membership is 0.9l.  Also as 
HAQ increases, we see a decrease in the predicted EQ-5D. The impact of gender is 
relatively small and varies in magnitude depending on the values of other covariates. 
Males have consistently lower predicted values of EQ-5D. The differences are much 
smaller than the linear regression which estimates a constant difference of 0.05. 
The improvement in model fit gained from the mixture model approach is very 
noticeable  at  the  lower  end  of the  HAQ  scale,  that  is,  where  patients  have  the 
least functional disability.  A recognised issue in modelling health utility data arises 
in the relatively poor model fit at the extremes of the health profile.  Figure 5 
illustrates that the mixture model fits extremely well between HAQ scores of 0 to 
l, unlike all the other non-mixture models which underpredict at HAQ of 0 (no 
functional disability) and systematically overpredict at HAQ scores between 0.3 and 
l.  Interestingly, we found that a mixture of normal distributions (not reported here) 
consistently  underpredicts  at  HAQ between  0.l5  and 0.9 suggesting  that  it is  the 
combination of mixture modelling and the ACM that is required.  Table 5 presents 
the  mean error,  MAE  and RMSE of all the  models  at  three  different  intervals  of 
HAQ.  The  ACMM  always  outperforms  the  other  models  in terms  of mean error 
and MAE. It also outperforms the other models in terms of RMSE between HAQ 
scores of 0 to l and l to 2. The RMSE of the ACMM  is only worse between HAQ 
scores of 2 to 3. Further investigation identified that this lower predictive ability of 
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Figure  4: Histograms of predicted values 
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the  RE  ACMM,  as judged  by the  RMSE,  is only for the  last  3 HAQ scores - 2. 75. 
 
2.875 and  3.  At these  levels of functional disability the  dataset has  an  extremely 
low number  of observations which appear  very different  and may be outliers. Up to 
and including  a HAQ score of 2.625, the  ACMM still outperforms the linear  model 
with  a RMSE for the interval  (2-2.625) of 0.2425 compared  to a RMSE for the linear 
model of 0.2427.  The  ACMM is more flexible than the other  models and is therefore 
sensitive  to these  extreme observations at  the  tails of the  distribution. 
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Figure 5:  Observed and predicted mean EQ-5D  by  HAQ (0 to1) 
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Table  1:  Parameter estimates (se) for linear,  Tobit  and  adjusted censored  models 
of EQ-5D 
 
 
RE Linear  Model  RE  Tobit REAdjusted 
Censored  Model 
 
Within HAQ  - 0.084 -0.165  -0.115 
(0.020)  (0.025)  (0.023) 
level HAQ2 -0.045 -0.022 -0.036 
(0.008) (0.009) (0.009) 
Vaspain/100 -0.478  -0.499  -0.484 
(0.027)  (0.028)  (0.028) 
(J2 0.028  0.032  0.030 E: (0.001) (0.002) (0.002) 
Between  Intercept 0.941 1.013  0.967 
(0.012) (0.017) (0.015) 
level Age-54.32 0.019  0.018 0.019 10 (0.005) (0.005) (0.005) 
2 
( Age; 4.32) 0.005  0.007  0.006 
(0.003) (0.003) (0.003) 
Male  -0.046 -0.047 -0.047 
(0.013)  (0.014)  (0.014) 
(J2 0.010  0.012 0.011 u (0.002) (0.002) (0.002) 
AIC                                                   -1058.17                  -345.55                  -558.84 
BIC                                                   -1007.75                  -295.13                  -508.42 
ME  (sd)                                    0.0003(0.194)         -0.0001(0.193)     0.0005(0.194) 
MAE  (sd)                                 0.1505(0.122)         0.1508(0.121)       0.1508(0.121) 
RMSE                                        0.1935                    0.1934                  0.1935 
 
A IC  -  Akaike Information  C riter ia , B IC 4  Ba y e s ian   Information C riter ia , 
 
ME   +   Mean  Error, MAE -  Mean Absolute  Error, RMSE +   Root  Mean Squared  Error 
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Table 2: Parameter estimates (se) for ACMM  model of EQ-5D 
 
 
Within  Latent class l HAQ  00062 
(0.0l5) 
level  HAQ2  - 
(-) 
VASpain/l00 00295 
(0.030) 
2 00015 1 (0.002) 
Latent class 2 HAQ  00245 
(0.044) 
HAQ2  0006 
(0.0l9) 
VASpain/l00 00105 
(0.l34) 
2 00006 2 (0.00l) 
Latent class 3 HAQ  00160 
(0.0l3) 
HAQ2  00025 
(0.005) 
VASpain/l00 00056 
(0.0l8) 
2 0000 3 (.000) 
Between  Latent class l Intercept 00  4 
(0.037) 
level  Latent class 2 Intercept 00990 
(.025) 
Latent class 3 Intercept 00  06 
(0.0ll) 
All  classes Age-54.32 00007 
(0.002)   Age-54.32   2 00004 l0 (0.00l) 
Male 00012 
(0.006) 
u 00002 (0.000) 
Within  Latent class l Intercept 50201 
(0.423) 
level  HAQ  20  6 
(0.l78) 
categorical  VASpain/l00 50179 
(0.433) 
latent Latent class 2 Intercept 2020 
(0.3l2) 
variables HAQ  004  5 
(0.2l4) 
VASpain/l00 110  66 
(4.227) 
AIC  -2051011 
BIC  -1911005 
ME (sd) -00000   (00192) 
 
MAE (sd) [% improvement) 0014 (0012  ) [4%) 
RMSE [% improvement) 00192 [1%) 
A I C  - A ka i k e  I n f o r m a t i o n  C r i t e r i a , B I C  - B a y e s i a n  I n f o r m a t i o n  C r i t e r i a , 
 
M E  - M e a n  E r r o r , M A E  - M e a n  A b s o l u t e  E r r o r , R M S E - R o o t M e a n  S q u a r e d  E r r o r 
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Table 3: Patient characteristics by most 
likely latent class (std.  dev.) 
 
 
Variable Class l Class 2 Class 3 
HAQ  2026(00  5) 00  7(0046) 1024(0060) 
VASpain 7201(1406) 00(205) 0    (1906) 
Age (yrs) 5405(1204) 5 0    (110  ) 5402(1206) 
Male 0025(0044) 00  9(0049) 00  2(0046) 
 
Table 4: Predicted EQ-5D values for the RE ACMM. 
 
 
Male, age 54 
HAQ  VASpain E-Q5D E-Q5Dl E-Q5D2 E-Q5D2 Pl P2 P3 
0              0           0.9430     0.3426      0.98l4        0.8l65      0.0005   0.7687   0.2308 
0             52          0.7724     0.l890       0.9520      0.78l8      0.0l74    0.0052   0.9773 
0             93          0.6942     0.0679      0.9l53       0.756l      0.0899   0.0000   0.9l00 
l      0           0.77l6      0.2806      0.8257      0.6704    0.0044   0.6626   0.333l 
l      52          0.5884     0.l270       0.7633      0.64l0      0.l032    0.0029   0.8940 
l      93          0.3790     0.0058      0.7l68       0.6l79      0.3903   0.0000   0.6097 
2              0           0.67ll       0.2l85       0.7760      0.5848    0.0374   0.5227   0.4399 
2             52          0.346l       0.0649      0.7l66       0.5555    0.4272   0.00ll    0.57l7 
2             93          0.0582    -0.0562     0.672l        0.5324    0.8057   0.0000   0.l943 
2.5            0           0.6299     0.l875       0.8094      0.5607    0.l0l4    0.4302   0.4684 
2.5           52          0.2056     0.0339      0.7479      0.53l4      0.655l    0.0005   0.3444 
2.5           93         -0.0357    -0.0872     0.7022      0.5083    0.9l34    0.0000   0.0866 
Female, age 54 
HAQ  VASpain E-Q5D E-Q5Dl E-Q5D2 E-Q5D2 Pl P2 P3 
0              0           0.9360     0.3307      0.9766      0.802l      0.0005   0.7687   0.2308 
0             52          0.7590     0.l77l        0.9430      0.7683    0.0l74    0.0052   0.9773 
0             93          0.68l4      0.0560      0.9033      0.7432    0.0899   0.0000   0.9l00 
l      0           0.7583     0.2686      0.8ll8      0.6584    0.0044   0.6626   0.333l 
l      52          0.5764     0.ll50        0.7502      0.629l      0.l032    0.0029   0.8940 
l      93          0.367l      -0.006l      0.7043      0.6060    0.3903   0.0000   0.6097 
2              0           0.6584     0.2066      0.7627      0.5729    0.0374   0.5227   0.4399 
2             52          0.3342     0.0530      0.704l        0.5436    0.4272   0.00ll    0.57l7 
2             93          0.0463    -0.068l      0.6600      0.5205    0.8057   0.0000   0.l943 
2.5            0           0.6l7l       0.l756       0.7957      0.5488    0.l0l4    0.4302   0.4684 
2.5           52          0.l937      0.0220      0.7350      0.5l95      0.655l    0.0005   0.3444 
2.5           93         -0.0476    -0.099l       0.6898      0.4964    0.9l34    0.0000   0.0866 
 
 
E-Q5D predicted EQ-5D, E-Q5Dspredicted EQ-5D for class s 
Ps probability of class s membership 
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Table 5: Measures of accuracy of predictions by HAQ interval. 
 
 
HAQ scores [0, l) (n - 75 ) 
 RE linear model RE Tobit RE ACM RE ACMM 
ME -0.0055 -0.0ll3 -0.0053 -0.0025 
MAE 0.l032 0.l034 0.l038 0.0955 
RMSE 0.l366 0.l363 0.l367 0.l328 
HAQ scores (l,2) (n - 91) 
 RE linear model RE Tobit RE ACM RE ACM 
ME 0.0040 0.0089 0.0048 0.00l9 
MAE 0.l670 0.l675 0.l67l 0.l603 
RMSE 0.2l09 0.2l08 0.2l09 0.2096 
HAQ scores (2,3) (n - 54) 
 RE linear model RE Tobit RE ACM RE ACM 
ME 0.0032 0.00ll 0.0022 -0.00l2 
MAE 0.2l0l 0.2l02 0.2l02 0.2057 
RMSE 0.2447 0.2449 0.2447 0.2467 
M E  - M e a n  E r r o r , M A E  - M e a n  A b s o l u t e  E r r o r , R M S E - R o o t M e a n  S q u a r e d  E r r o r 
 
 
 
5    Discussion 
 
 
Health related quality of life data typically exhibit distributional properties that 
raise numerous statistical challenges.  In some respects these are more complex than 
those that arise in relation to healthcare costs, where there has been substantial 
attention given to the development and application of flexible statistical models to 
deal with issues such as repeated measures, skewness and left censoring (Hernandez 
Alava and Wailoo (20l0)). 
Whilst standard models and methods for dealing with censoring have been ap- 
plied when modelling health state utilities, these offer only limited and partial so- 
lutions to these challenges.  A common feature arising from the limitations of such 
models is poor fit at the extremes of the distribution.  The commonly used Tobit and 
other censored regression models offer a method for dealing with the upper bound 
of full health in health utility data.  We have developed a censored regression model 
that provides a more appropriate method to reflect the gap between full health and 
intermediate health states, a particular feature that results from the approach used 
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to generate the EQ-5D tariff.  Only limited consideration has been given to the use 
of latent class mixture models in this field to date.  The small number of studies that 
have considered the approach have focussed on the issue of ceiling effects, Huang et 
al. (2008), Pullenayegum et al. (20l0). 
When  considering  measures  of model  fit we use penalised  likelihood  measures. 
When we compared the models using data from a clinical trial of patients with 
rheumatoid arthritis, we found that the linear regression outperforms either of the 
censored regression models.  This is because our dataset exhibits a relatively large 
peak of observations around an EQ-5D value of 0.5.  This pulls the estimates from 
the  linear  regression  down and diminishes  the  importance  of the  values  at  high 
EQ-5D scores,  where  differences  betwen  the  EQ-5D and censored  models  will  be 
more profound. The linear regression does not predict unfeasible values within the 
observed dataset but may do so in a different sample where patients exhibit different 
characteristics to those included in this trial.  This is of critical importance when 
considering the intended use of such models in cost effectiveness analyses.  Here it is 
typical to simulate patients with varying characteristics and over long time periods. 
These models can be expected to cover a wide range of functional disability, pain and 
other relevant patient characteristics such that it is likely that implausible predicted 
values will be generated.  In this situation the analyst may need to artificially censor 
the predicted values themselves. Thus, there are clear dangers with a reliance on 
model  fit alone in model selection in this situation.  The adjusted censored model 
improves  both  model  fit and provides  a more faithful  reflection  of the  underlying 
data compared to standard censored models such as the Tobit model. 
This paper develops the approach further by employing mixture models.  Mixture 
models offer a highly flexible tool that can be used to deal with the remaining 
distributional challenges.  Each of the mixture models we considered offered vastly 
superior performance compared to standard linear regression and censored regression 
models.   In particular,  we demonstrate  that  this  model  predicts  accurately  at  the 
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highest EQ-5D and maintains this high degree of predictive accuracy across the EQ- 
 
5D range.  Only where data is sparse does this accuracy decrease.  This is the first 
application of censored mixture models in this area that we are aware of. 
Our preferred model specification identifies three latent classes clearly distin- 
guished by the relative role of functional disability and pain in determining EQ-5D 
utility values.  The model is formed as a mixture of adjusted censored distributions. 
Our findings also have specific implications for cost effectiveness modelling of 
interventions in rheumatoid arthritis.  First, it is clear that estimates of health state 
utilities are improved by the inclusion of pain and other patient level covariates 
rather than functional ability alone.  Since pain is not a feature of the HAQ score 
but is a heavily weighted component of the EQ-5D tariff the finding is perhaps not 
surprising.  Standard composite outcome measures used in RA clinical trials and ob- 
servational datsets, such as the American College of Rheumatology (ACR) response 
criteria, include VAS pain as one of the components.  Where treatment effects are ob- 
served on pain as well as function, appropriate statistical models to estimate health 
state utilities become critical to avoid biased estimates of cost effectiveness.  In order 
for researchers to make use of the estimates in the proposed mixture models and the 
associated uncertainty, the full variance covariance matrix is available from the fol- 
lowing website (www.sheffield.ac.uk/scharr/sections/heds/dps-20l0.html) and the 
expression for the predicted values in the appendix. 
There are several potential limitations.  The approach treats the values from the 
EQ-5D tariff as if they were data rather than estimates.  The uncertainty in the 
original regression  work reported  by Dolan et  al. (l995)  is  ignored.   Furthermore, 
the challenges that arise from the distributional characteristics of the EQ-5D tariff 
may be  avoidable.   The  method  by which EQ-5D values  are  generated  is  based 
on simple  linear  regression  model  that  itself  does  not  perform  well  and does  not 
apply a consistent approach to the values assigned to full health versus all other 
intermediate  health  states.   The  application  of more flexible  models  to  generate 
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the EQ-5D tariff may result in less statistical challenges for analysts that need to 
estimate  the  relationship  with  clinical and sociodemographic  variables.   We  note 
that health state utilities generated from the EQ-5D in different populations exhibit 
the same distributional features as the data presented here, see for example Huang 
et al. (2008). Nevertheless, there may also be value in examining the performance 
of the mixture of adjusted censored features of distributions for health utility data 
generated from instruments other than the EQ-5D. 
The dataset on which the analyses are based is from a group of patients with 
early RA at the point of entry to the study.  Despite the fact that the estimates span 
two years of follow up and we found no evidence of a time trend, it may be the case 
that patients with more established disease do not exhibit the same relationships 
between EQ-5D, pain and function.  For example, there may be a greater degree of 
adaptation to functional decline in later disease that is reflected to a greater degree 
in  HAQ  than  EQ-5D. In addition,  the  dataset  includes  few  observations  at  the 
most extreme level of functional disability, with outliers perhaps exerting a strong 
influence on the model.  Therefore, further refinement of the ACMM in an additional 
dataset of established disease may be useful. 
In summary, it is clear that the mixture modelling approach provides a general 
framework which can reflect the specific distributional characteristics of health utility 
data.  When combined with the adjusted censored distribution it is possible to obtain 
a flexible model that vastly outperforms standard linear regression and censored 
regression approaches. 
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Appendix 
 
EQ-5D predictions using the random effects ACMM. 
 
This appendix derives the expression for the prediction of EQ-5D using the 
ACMM  model with a random intercept.  Conditional on an observation belonging 
to class Cit, the random effects ACMM  model can be written as: 
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where  f3i   is  a (k x 1) vector  of coefficients  f3ki,  xit  is  a row vector  of level  l 
covariates,   i is  a row vector  of level  2 covariates,  Eit   is  l l D  N (0, 02 ), ui   is  l l D 
N (0, 02 ) and Eit  is independent of ui.  A multinomial logit model for the probability 
of latent class membership is assumed  as follows: 
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where wt is a vector of variables that affect the probability of class membership, 8c 
is the vector of corresponding coefficients and P is the number of classes (P - in 
the final model used in our analysis). 
The EQ-5D prediction based on this model, E 
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, is calculated using 
the following expression: 
 
E   yit\xit,  i , w
t 
 
 
 
- Eui 
 
 
 
E   yit\xit, 
 
l 
i , ui 
 
1 
( 
ui 
\ 
- E   y 
 
\x  , 
 
, wt  , u du 0u 0u 
-  
it it i i  i i 
 
where   (0) is the standard normal density function and 
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In the last equation <P (0) is the standard cumulative normal and W - 00 . 
